Dow’s Dastardly Deeds
Above Photo: Flickr/ Francisco Javier Argel
With Monsanto looking to be acquired by Germany-based Bayer, is Dow Chemical taking over Monsanto’s role of chief influence-buyer in Washington, D.C.?
Dow wasted no time wooing Trump—the poison-peddler ponied up $1 million for the new president’s inauguration festivities. Trump swiftly rewarded Dow by naming CEO Andrew Liveris to head a new White House manufacturing working group.
In February, after Trump signed an executive order aimed at rolling back regulations (including those on pesticides and GMOs), he handed the pen to Liveris. Fitting, given that Trump’s new EPA chief, Scott Pruitt, was quick to overturn the Obama administration’s proposed ban on one of Dow’s moneymakers, chlorpyrifos, an organophosphate pesticide. (Pruitt’s move prompted a lawsuit by environmental groups).
Now, it seems, just banning organophosphates isn’t enough. A new report by the Associated Press (AP) says lawyers for Dow and two other manufacturers of organophosphates are asking Trump’s administration to throw out the EPA’s own studies on the dangerous effects of chlorpyrifos and other organophosphates, known to lower I.Q.s and cause neurological damage in children.
From the AP report:
Organophosphorus gas was originally developed as a chemical weapon by Nazi Germany. Dow has been selling Chlorpyrifos for spraying on citrus fruits, apples, cherries and other crops since the 1960s. It is among the most widely used agricultural pesticides in the United States, with Dow selling about 5 million pounds domestically each year.
As a result, traces of the chemical are commonly found in sources of drinking water. A 2012 study at the University of California at Berkeley found that 87 percent of umbilical-cord blood samples tested from newborn babies contained detectable levels of chlorpyrifos.
OCA’s Alexis Baden-Mayer appeared on RT America this week to talk about Dow’s latest dastardly deeds.